Distribution and excretion of fluoxetine and norfluoxetine in human milk

British Journal of Clinical Pharmacology

Volumn 48, Issue 4, 1999, Pages 521-527

  Kristensen, J H ^a,d   Ilett, K F ^b,c   Hackett, L P ^b   Yapp, P ^a   Paech, M ^d   Begg, E J ^e  

^a King Edward Mem and Prncs MH ^*  (Australia)

^b W Australian Inst Pathol Med R   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d KING EDWARD MEMORIAL HOSPITAL   (Australia)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Fluoxetine; Human milk; In utero exposure; Infant dose; Norfluoxetine

Indexed keywords

FLUOXETINE; NORFLUOXETINE;

ADULT; ARTICLE; BODY WEIGHT; BREAST FEEDING; BREAST MILK; CLINICAL ARTICLE; CLINICAL TRIAL; COLIC; DEPRESSION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MONITORING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; ANIMALS; BREAST FEEDING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOXETINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MILK; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0032869573     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00040.x     Document Type: Article

References (16)

1. 1 Buist A. Psychiatric disorders associated with childbirth. A guide to management. Sydney, McGraw-Hill 1991.
2. 2 Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 1994; 26: 201-214.
3. 3 Isenberg KE. Excretion of fluoxetine in human breast milk. J Clin Psychiat 1990; 52: 169.
4. 4 Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Paediatrics 1992; 89: 676-677.
5. 5 Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Adolesc Psychiat 1993; 32: 1253-1255.
6. 6 Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36: 42-47.
7. 7 Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998; 37: 41-44.
8. 8 Yoshida K, Smith B, Craggs M, Channi Kumar R. Fluoxetine in breast milk and developmental outcome of breast-fed infants. Br J Psychiat 1998; 172: 175-179.
9. 9 Bennett PN. Use of the monographs on drugs. In Drugs and human lactation, 2nd edn, ed. Bennett PN. Elsevier, Amsterdam, 1996: pp. 67 74.
10. 10 Atkinson HC, Begg EJ. Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet 1990; 18: 151-167.
11. 11 Neville MC, Keller RP, Scarat J, Casey CE, Allen JC, Archer P. Studies on human lactation.1. Within-feed and between-breast variation in selected components of human milk. Am J Clin Nutrit 1984; 40: 645-646.
12. 12 Duffull SB, Begg EJ, Ilett KF. Fluoxetine distribution in human milk (letter). Br J Clin Pharmacol 1996; 36: 1078.
13. 13 Australian Adverse Drug Reactions Bulletin 1997; 16: 14.
14. 14 Begg EJ, Atkinson HC, Duffull SB. Prospective evaluation of a model for the prediction of milk: plasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 1992; 33: 501-505.
15. 15 Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258-262.
16. 16 Nulman I, Koren G. The safety of fluoxetine during pregnancy and lactation. Teratology 1996; 53: 304-308.